Mana Capital and Cardio Diagnostics Amend Merger Agreement to Increase Incentive Plan Shares and Provide Equity to UIRF

Cardio Diagnostics Holdings, Inc.

Amendment dated September 15, 2022 increases shares reserved under Cardio Diagnostics Holdings 2022 Incentive Plan to 3,265,516.
Upon closing, University of Iowa Research Foundation to receive 1% of aggregate merger consideration as common stock of Mana Capital.
Amendment modifies treatment of Company Equity Rights and adjusts Exchange Ratio definition in the Merger Agreement.
Other terms of the original Merger Agreement dated May 27, 2022 remain in full force and effect.
Business combination still subject to stockholder approval and customary closing conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.